In patients with heart failure, SGLT2 inhibitors after TAVI are associated with major risk reductions in a clinical trial ...

Kolkata: The National Pharmaceutical Pricing Authority (NPPA), in an order dated March 27, changed the prices of 80 medicines ...

Patients with aortic stenosis were excluded from earlier trials of the SGLT2 inhibitor, but new data confirm they too can ...

Dapagliflozin, metformin HCl ext-rel ... capsule-shaped; "1072" and "10/500" debossed on one side and plain on the reverse side; Bottle of 30 10mg/1000mg – yellow to dark yellow, biconvex ...

Pioglitazone/metformin FDC with dapagliflozin may provide effective and safe management for Type 2 diabetes. Read more!

As heart failure patients, the TAVI population studied already is recommended to be treated with an SGLT2 inhibitor, noted ...

SGLT2 inhibitors vs placebo were associated with reduced heart failure hospitalization among patients with history of myocardial infarction.